André Galarneau - Concepedia

Concepedia

Author

André Galarneau

Jewish General Hospital

Also Known As

A. Galarneau, Andre Galarneau, André Galarneau

17

Publications

1.2K

Citations

8

H-Index

13

Concepts

All Affiliations

Jewish General Hospital McGill University Merck & Co., Inc., Rahway, NJ, USA (United States)Université de Montréal Hôpital Maisonneuve-Rosemont

AG

About

André Galarneau is an author at Jewish General Hospital specializing in medicine, gene expression, and non-coding rna.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	858
2	Cell Biology	2	2	452
3	Natural Sciences	1	1	288
4	Biochemistry	1	1	406
5	Microbiology	1	1	406

André Galarneau

×

7

Publications

1.2K

Citations

7

H-Index

	Year	Citations
β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactions André Galarneau, Martin Primeau, Louis‐Éric Trudeau, Nature Biotechnology Protein ChemistryProtein–protein InteractionsBiochemistryProtein FoldingBiomolecular Analysis	2002	406
Target RNA motif and target mRNAs of the Quaking STAR protein André Galarneau, Stéphane Richard Nature Structural & Molecular Biology Target MrnasFunctional GenomicsNatural SciencesQuaking Star ProteinRna Structure Prediction	2005	288
The RECITE Study Louis‐Philippe Fortier, Dolores M. McKeen, Kim Turner, Anesthesia & Analgesia	2015	184
Protection of p27Kip1 mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation Daniel Larocque, André Galarneau, Hsueh‐Ning Liu, Nature Neuroscience Developmental BiologyP27kip1 MrnaRna BiologyProteins PromotesGene Expression	2004	164
The STAR RNA binding proteins GLD-1, QKI, SAM68 and SLM-2 bind bipartite RNA motifs André Galarneau, Stéphane Richard BMC Molecular Biology	2009	78
A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada Ralph P. Insinga, Cédric Joyal, A. Goyette, BMC Anesthesiology	2016	22
Phase <scp>II</scp> study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O<sup>6</sup>‐methylguanine DNA methyltransferase expression Joseph Brandwein, Jeannine Kassis, Brian Leber, British Journal of Haematology	2014	16

Page 1